AAAAAA
Results: 1-25/28
Authors:
Holzner, B
Kemmler, G
Sperner-Unterweger, B
Kopp, M
Dunser, M
Margreiter, R
Marschitz, I
Nachbaur, D
Fleischhacker, WW
Greil, R
Citation: B. Holzner et al., Quality of life measurement in oncology - a matter of the assessment instrument?, EUR J CANC, 37(18), 2001, pp. 2349-2356
Authors:
Moschen, R
Kemmler, G
Schweigkofler, H
Holzner, B
Dunser, M
Richter, R
Fleischhacker, WW
Sperner-Unterweger, B
Citation: R. Moschen et al., Use of alternative/complementary therapy in breast cancer patients - a psychological perspective, SUPP CARE C, 9(4), 2001, pp. 267-274
Authors:
Marksteiner, J
Weiss, U
Weis, C
Laslop, A
Fischer-Colbrie, R
Humpel, C
Feldon, J
Fleischhacker, WW
Citation: J. Marksteiner et al., Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment, NEUROSCIENC, 104(2), 2001, pp. 325-333
Authors:
Fleischhacker, WW
Lemmens, P
van Baelen, B
Citation: Ww. Fleischhacker et al., A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database, PHARMACOPS, 34(3), 2001, pp. 104-110
Authors:
Meltzer, HY
Fleischhacker, WW
Citation: Hy. Meltzer et Ww. Fleischhacker, Weight gain: A growing problem in schizophrenia management, J CLIN PSY, 62, 2001, pp. 3-3
Authors:
Kurzthaler, I
Fleischhacker, WW
Citation: I. Kurzthaler et Ww. Fleischhacker, The clinical implications of weight gain in schizophrenia, J CLIN PSY, 62, 2001, pp. 32-37
Authors:
Holzner, B
Kemmler, G
Kopp, M
Moschen, R
Schweigkofler, H
Dunser, M
Margreiter, R
Fleischhacker, WW
Sperner-Unterweger, B
Citation: B. Holzner et al., Quality of life in breast cancer patients - Not enough attention for long-term survivors?, PSYCHOSOMAT, 42(2), 2001, pp. 117-123
Authors:
Bodner, T
Jenner, C
Benke, T
Ober, A
Seppi, K
Fleischhacker, WW
Citation: T. Bodner et al., Intoxication with riluzole in Huntington's disease, NEUROLOGY, 57(6), 2001, pp. 1141-1143
Authors:
Eder, U
Mangweth, B
Ebenbichler, C
Weiss, E
Hofer, A
Hummer, M
Kemmler, G
Lechleitner, M
Fleischhacker, WW
Citation: U. Eder et al., Association of olanzapine-induced weight gain with an increase in body fat, AM J PSYCHI, 158(10), 2001, pp. 1719-1722
Authors:
Hausmann, A
Fleischhacker, WW
Citation: A. Hausmann et Ww. Fleischhacker, Depression in patients with schizophrenia - Prevalence, and diagnostic andtreatment considerations, CNS DRUGS, 14(4), 2000, pp. 289-299
Authors:
Fleischhacker, WW
Citation: Ww. Fleischhacker, Methodological challenges in the clinical development of antipsychotic drugs, CUR OPIN P, 13(1), 2000, pp. 1-2
Authors:
Kopp, M
Schweigkofler, H
Holzner, B
Nachbaur, D
Niederwieser, D
Fleischhacker, WW
Kemmler, G
Sperner-Unterwerger, B
Citation: M. Kopp et al., EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison, EUR J HAEMA, 65(2), 2000, pp. 97-103
Authors:
Bauer, R
Mayr, A
Lederer, W
Needham, PL
Kilpatrick, IC
Fleischhacker, WW
Marksteiner, J
Citation: R. Bauer et al., Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs, NEUROPSYCH, 23(1), 2000, pp. 46-55
Authors:
Weiss, E
Hummer, M
Koller, D
Ulmer, H
Fleischhacker, WW
Citation: E. Weiss et al., Off-label use of antipsychotic drugs, J CL PSYCH, 20(6), 2000, pp. 695-698
Authors:
Hofer, A
Hummer, M
Huber, R
Kurz, M
Walch, T
Fleischhacker, WW
Citation: A. Hofer et al., Selection bias in clinical trials with antipsychotics, J CL PSYCH, 20(6), 2000, pp. 699-702
Authors:
Deisenhammer, EA
Whitworth, AB
Geretsegger, C
Kurzthaler, I
Gritsch, S
Miller, CH
Fleischhacker, WW
Stuppack, CH
Citation: Ea. Deisenhammer et al., Intravenous versus oral administration of amitriptyline in patients with major depression, J CL PSYCH, 20(4), 2000, pp. 417-422
Authors:
Miller, CH
Fleischhacker, WW
Citation: Ch. Miller et Ww. Fleischhacker, Managing antipsychotic-induced acute and chronic akathisia, DRUG SAFETY, 22(1), 2000, pp. 73-81
Authors:
Oehl, M
Hummer, M
Fleischhacker, WW
Citation: M. Oehl et al., Compliance with antipsychotic treatment, ACT PSYC SC, 102, 2000, pp. 83-86
Authors:
Deisenhammer, EA
DeCol, C
Honeder, M
Hinterhuber, H
Fleischhacker, WW
Citation: Ea. Deisenhammer et al., In-patient suicide in psychiatric hospitals, ACT PSYC SC, 102(4), 2000, pp. 290-294
Authors:
Fleischhacker, WW
Marksteiner, J
Citation: Ww. Fleischhacker et J. Marksteiner, Future perspectives in antipsychotic drug development, PHARM TOXIC, 2000, pp. 243-246
Authors:
Fleischhacker, WW
Citation: Ww. Fleischhacker, The psychopharmacology of schizophrenia, CUR OPIN P, 12(1), 1999, pp. 53-59
Authors:
Sperner-Unterweger, E
Miller, C
Holzner, B
Widner, B
Fleischhacker, WW
Fuchs, D
Citation: E. Sperner-unterweger et al., Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients, KEY T BRAIN, 1999, pp. 115-119
Authors:
Sperner-Unterweger, B
Whitworth, A
Kemmler, G
Hilbe, W
Thaler, J
Weiss, G
Fleischhacker, WW
Citation: B. Sperner-unterweger et al., T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients, SCHIZOPHR R, 38(1), 1999, pp. 61-70
Authors:
Fleischhacker, WW
Hummer, M
Citation: Ww. Fleischhacker et M. Hummer, Do phase III trials have clinical value?, J CL PSYCH, 19(5), 1999, pp. 391-392
Authors:
Kurzthaler, I
Hummer, M
Miller, C
Sperner-Unterweger, B
Gunther, V
Wechdorn, H
Battista, HJ
Fleischhacker, WW
Citation: I. Kurzthaler et al., Effect of cannabis use on cognitive functions and driving ability, J CLIN PSY, 60(6), 1999, pp. 395-399